Valuation GlaxoSmithKline plc Liquidnet

Stocks

Delayed Liquidnet			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

09:55am	Pharma sector doubles down on AI to slash costs, timelines	RE
03:00am	UK inflation rises; Barratt cuts completions outlook	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	74,290	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	1.49%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	94,971	92,258	89,381
Change	-	-24.65%	-1.89%	-8.24%	28.83%	8.35%	-2.86%	-3.12%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.2x	11.8x	10.8x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.53x	3.98x	3.51x
PEG	-	0x	-0.2x	-0.4x	0x	-1.86x	0.6x	1.22x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.19x	2.09x	2.03x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.8x	2.6x	2.44x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.28x	7.52x	7.03x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.21x	8.35x	7.75x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.1x	15.9x	13.1x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.84%	6.28%	7.61%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7494	0.7843
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.75%	4.04%	4.23%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.303	1.571	1.71
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	53.4%	47.7%	45.9%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,934	35,504	36,608
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,466	12,264	12,707
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,310	11,046	11,531
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,348	6,284	6,856
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	20,681	17,968	15,091
Reference price ²	20.08	14.38	14.50	13.46	18.24	18.54	18.54	18.54
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.3x	11.75x	23.82x	0.61%	1,013B
JOHNSON & JOHNSON	29.72x	6.61x	18.51x	2.01%	644B
ABBVIE INC.	33.26x	7.79x	16.1x	2.61%	465B
ROCHE HOLDING AG	19.53x	4.77x	11.83x	2.78%	352B
NOVARTIS AG	19.64x	5.13x	12.73x	3.13%	264B
ASTRAZENECA PLC	20.94x	4.32x	12.33x	2.04%	253B
AMGEN INC.	23.76x	6.28x	11.19x	2.69%	203B
NOVO NORDISK A/S	12.28x	4.47x	9.35x	4.09%	188B
GILEAD SCIENCES, INC.	-44.25x	6.45x	25.21x	2.25%	181B
Average	16.35x	6.40x	15.67x	2.47%	395.97B
Weighted average by Cap.	23.51x	7.63x	17.62x	2.01%